Pharmacogenetics as a Predictor of Toxicity in Pre-Menopausal Women Receiving Doxorubicin and Cyclophosphamide in Early Breast Cancer
Status: TERMINATED
Study type: OBSERVATIONAL
Conditions: Breast Cancer
Sponsor: Indiana University School of Medicine